Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Michael John Peck, Edward B. Sanders, Gerhard Scherer, Frank Lüdicke & Rolf Weitkunat. (2018) Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products. Biomarkers 23:3, pages 213-244.
Read now
Read now
Heeyoung Jang, Deokyeong Choe & Chul Soo Shin. (2014) Novel derivatives of monascus pigment having a high CETP inhibitory activity. Natural Product Research 28:18, pages 1427-1431.
Read now
Read now
Articles from other publishers (39)
Bilal Bashir, Zohaib Iqbal, Jonathan Schofield & Handrean Soran. 2023. Cardiovascular Endocrinology and Metabolism. Cardiovascular Endocrinology and Metabolism
97
135
.
Ratih Dewi Yudhani, Khariz Fahrurrozi & Dono Indarto. (2022) New Cholesteryl Ester Transfer Protein from Indonesian Herbal Plants as Candidate Treatment of Cardiovascular Disease. Open Access Macedonian Journal of Medical Sciences 10:A, pages 1624-1629.
Crossref
Crossref
Zahra Kalantar, Gity Sotoudeh, Zahra Esmaeily, Masoumeh Rafiee & Fariba Koohdani. (2021) Interaction between CETP Taq1B polymorphism and HEI, DQI and DPI on metabolic biomarkers in patients with type 2 diabetes. Journal of Human Nutrition and Dietetics 35:4, pages 651-662.
Crossref
Crossref
Isabel Gamache, Marc-André Legault, Jean-Christophe Grenier, Rocio Sanchez, Eric Rhéaume, Samira Asgari, Amina Barhdadi, Yassamin Feroz Zada, Holly Trochet, Yang Luo, Leonid Lecca, Megan Murray, Soumya Raychaudhuri, Jean-Claude Tardif, Marie-Pierre Dubé & Julie Hussin. (2021) A sex-specific evolutionary interaction between ADCY9 and CETP. eLife 10.
Crossref
Crossref
Hua Yang, Ronghua Pan, Jing Wang, Lizhong Zheng, Zhenjing Li, Qingbin Guo & Changlu Wang. (2021) Modulation of the Gut Microbiota and Liver Transcriptome by Red Yeast Rice and Monascus Pigment Fermented by Purple Monascus SHM1105 in Rats Fed with a High-Fat Diet. Frontiers in Pharmacology 11.
Crossref
Crossref
Víctor Toro Román, Diego Muñoz Marín, Jesús Siquier Coll, Ignacio Bartolomé Sánchez, Julio Montero Arroyo, Mario Pérez Quintero & Marcos Maynar Mariño. (2020) Efectos de un protocolo de ayuno intermitente sobre la composición corporal y perfil lipídico en estudiantes universitarios. Archivos Latinoamericanos de Nutrición 69:3, pages 157-164.
Crossref
Crossref
Wilson Alberto TárragaHoracio Alberto GardaJuan Domingo ToledoMarina Cecilia Gonzalez. (2019) Potential Inhibitors of the Activity of the Cholesterol-Ester Transfer Protein. Journal of Computational Biology 26:12, pages 1458-1469.
Crossref
Crossref
Justyna Pawlik & Dorota Wrześniok. (2019) Cholesteryl ester transfer protein: the physiological and molecular characteristics in the pathogenesis of atherosclerosis and Alzheimer’s disease. Postępy Higieny i Medycyny Doświadczalnej 73, pages 387-396.
Crossref
Crossref
Saverio Cinti. 2011. Comprehensive Physiology. Comprehensive Physiology
1357
1431
.
Heitor O. Santos & Rodrigo C.O. Macedo. (2018) Impact of intermittent fasting on the lipid profile: Assessment associated with diet and weight loss. Clinical Nutrition ESPEN 24, pages 14-21.
Crossref
Crossref
Nicola Ferri, Alberto Corsini, Cesare R. Sirtori & Massimiliano Ruscica. (2018) Present therapeutic role of cholesteryl ester transfer protein inhibitors. Pharmacological Research 128, pages 29-41.
Crossref
Crossref
Zahra Kalantar, Mohamad Reza Eshraghian, Gity Sotoudeh, Mahmoud Djalali, Anahita Mansouri, Ehsan Alvandi, Fatemeh Javadi, Maryam Mahmoudi & Fariba Koohdani. (2018) Differences in the interaction between CETP Taq1B polymorphism and dietary fat intake on lipid profile of normolipedemic and dyslipidemic patients with type 2 diabetes mellitus. Clinical Nutrition 37:1, pages 270-275.
Crossref
Crossref
Daehwan Kim & Seockmo Ku. (2018) Beneficial Effects of Monascus sp. KCCM 10093 Pigments and Derivatives: A Mini Review. Molecules 23:1, pages 98.
Crossref
Crossref
Raul Cavalcante Maranhão, Antonio Casela Filho, Gilbert Alexandre Sigal, Antonio Carlos Palandri Chagas & Protásio Lemos da Luz. 2018. Endothelium and Cardiovascular Diseases. Endothelium and Cardiovascular Diseases
297
317
.
Christopher J. Schmoyer & Mohammad S. Siddiqui. (2017) Non-alcoholic Fatty Liver Disease in Non-obese Patients. Current Hepatology Reports 16:4, pages 382-390.
Crossref
Crossref
Amirhossein Sahebkar, Anna Hernández-Aguilera, David Abelló, Elena Sancho, Jordi Camps & Jorge Joven. (2016) Systematic review and meta-analysis deciphering the impact of fibrates on paraoxonase-1 status. Metabolism 65:5, pages 609-622.
Crossref
Crossref
Xavier Pintó & María Carmen García Gómez. (2016) Nuevos tratamientos para la hipercolesterolemia. Medicina Clínica 146:4, pages 172-177.
Crossref
Crossref
Xavier Pintó & María Carmen García Gómez. (2016) New agents for hypercholesterolemia. Medicina Clínica (English Edition) 146:4, pages 172-177.
Crossref
Crossref
Mostafa Jamalan, Majid Zeinali & Mohammad Ali Ghaffari. (2015) A molecular dynamics investigation on the inhibition mechanism of cholesteryl ester transfer protein by Anacetrapib. Medicinal Chemistry Research 25:1, pages 62-69.
Crossref
Crossref
David S. Small, Alice Ban Ke, Stephen D. Hall, Nathan Mantlo, Matthew Rotelli & Stuart Friedrich. (2015) Assessment of the persistence of anacetrapib and evacetrapib concentrations using two pharmacokinetic modeling approaches. The Journal of Clinical Pharmacology 55:7, pages 757-767.
Crossref
Crossref
Gregory D. Sloop, Joseph J. Weidman & John A. St.Cyr. (2015) Perspective The failure of cholesteryl ester transfer protein inhibitors: is it due to increased blood viscosity?. Therapeutic Advances in Cardiovascular Disease 9:2, pages 32-35.
Crossref
Crossref
Frans C. SchuitFrans C. Schuit. 2015. Leerboek metabolisme. Leerboek metabolisme
195
233
.
Jessica Sparks Lilley, MacRae F. Linton & Sergio Fazio. 2015. Dyslipidemias. Dyslipidemias
221
233
.
Ulf G. Bronas & Dereck Salisbury. (2013) Clinical Strategies for Managing Dyslipidemias. American Journal of Lifestyle Medicine 8:4, pages 216-230.
Crossref
Crossref
Navjot Kaur, Avaneesh Pandey, Harish Negi, Nusrat Shafiq, Srinivas Reddy, Harpreet Kaur, Neelima Chadha & Samir Malhotra. (2014) Effect of HDL-Raising Drugs on Cardiovascular Outcomes: A Systematic Review and Meta-Regression. PLoS ONE 9:4, pages e94585.
Crossref
Crossref
Stephen F. RodriguesLidiana D. Almeida-PaulaDaniel N. Granger. (2014) Synergistic Effects of High Blood Cholesterol and Hypertension on Leukocyte and Platelet Recruitment in the Cerebral Microcirculation. Hypertension 63:4, pages 747-752.
Crossref
Crossref
Norman E Miller. (2014) CETP inhibitors and cardiovascular disease: Time to think again. F1000Research 3, pages 124.
Crossref
Crossref
Ruo-Long Zeng. (2014) Effect of CETP Polymorphism on Atorvastatin Lipid-Regulating Effect and Clinical Prognosis of Patients with Coronary Heart Disease. Medical Science Monitor 20, pages 2824-2829.
Crossref
Crossref
Raul C. Maranhão & Fatima R. Freitas. 2014.
1
41
.
Céline Verdier, Laurent O. Martinez, Jean Ferrières, Meyer Elbaz, Annelise Genoux & Bertrand Perret. (2013) Targeting high-density lipoproteins: Update on a promising therapy. Archives of Cardiovascular Diseases 106:11, pages 601-611.
Crossref
Crossref
Ramesh Mullangi & Nuggehally R. Srinivas. (2013) Review of the quantitative analysis of cholesteryl ester transfer protein inhibitors. Biomedical Chromatography 27:10, pages 1259-1272.
Crossref
Crossref
Amir Hooshang Mohammadpour & Fatemeh Akhlaghi. (2013) Future of Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Pharmacological Perspective. Clinical Pharmacokinetics 52:8, pages 615-626.
Crossref
Crossref
Andrew L. SiebelAlaina K. NatoliFelicia Y. T. YapAndrew L. CareyMedini Reddy-LuthmoodooDmitri SviridovChek Ing Kiu WeberGeorgina Meneses-LorenteCyrille MaugeaisJosephine M. ForbesBronwyn A. Kingwell. (2013) Effects of High-Density Lipoprotein Elevation With Cholesteryl Ester Transfer Protein Inhibition on Insulin Secretion. Circulation Research 113:2, pages 167-175.
Crossref
Crossref
Richard Kones. (2013) Reducing residual risk: modern pharmacochemistry meets old-fashioned lifestyle and adherence improvement. Therapeutic Advances in Cardiovascular Disease 7:3, pages 169-182.
Crossref
Crossref
Jane Hoover-Plow & Menggui Huang. (2013) Lipoprotein(a) metabolism: Potential sites for therapeutic targets. Metabolism 62:4, pages 479-491.
Crossref
Crossref
Bo Zhang, Emi Kawachi, Shin-ichiro Miura, Yoshinari Uehara, Akira Matsunaga, Masahide Kuroki & Keijiro Saku. (2013) Therapeutic Approaches to the Regulation of Metabolism of High-Density Lipoprotein. Circulation Journal 77:11, pages 2651-2663.
Crossref
Crossref
Angela Pirillo, Giuseppe Danilo Norata & Alberico Luigi Catapano. (2013) High-Density Lipoprotein Subfractions - What the Clinicians Need to Know. Cardiology 124:2, pages 116-125.
Crossref
Crossref
Shengjun Fan, Qiang Geng, Zhenyu Pan, Xin Li, Lu Tie, Yan Pan & Xuejun Li. (2012) Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach. BMC Systems Biology 6:1.
Crossref
Crossref
Gerhard Laus, Volker Kahlenberg, Frank Richter, Sven Nerdinger & Herwig Schottenberger. (2012) Improved Synthesis and Crystal Structure of Dalcetrapib. Crystals 2:4, pages 1455-1459.
Crossref
Crossref